CTOR
Citius Oncology, Inc.
1.10$
+4.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | +11.8% | +76.7% | +19.6% | |
| – | – | +187.5% | +41.8% | +151.1% | |
| – | – | -90.8% | -99.6% | +3,504,282.1% | |
| – | – | – | – | +3,504,282.1% | |
| – | – | – | – | +169.5% | |
| – | – | +0.0% | +83.5% | +0.0% | |
| – | – | +245.6% | +72.2% | +46.7% | |
| – | – | +260.0% | +55.4% | +51.3% | |
| – | – | +1,296.4% | +187.9% | +256.6% | |
| – | – | – | – | +0.0% | |
| – | – | -29.6% | +80.7% | -2.8% | |
| – | – | – | – | – | |
| – | +10.8% | -0.8% | -20.0% | +2.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.